Washington University School of Medicine: Melanoma trials

The registry lists 11 Melanoma studies with Washington University School of Medicine as lead sponsor. 3 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 5Phase 2 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseRecruitingNCT06529822Phase 1
• Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint InhibitorsRecruitingNCT05629546Phase 1
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following ResectionTerminatedNCT05060003Phase 2Results posted
• Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain MetastasisTerminatedNCT03903640Phase 2Results posted
• 18F-FLT PET Imaging in Patients With Advanced MelanomaTerminatedNCT02891616Phase 1
• fPAM for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma DepthCompletedNCT02613325Phase 1
• Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and MelanomaCompletedNCT02316795Early Phase 1
• Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity MelanomaWithdrawnNCT01531244Phase 1/2
• Feasibility and Functionality of fPAM Imaging in MelanomaTerminatedNCT00776945
• Validation of a Molecular Prognostic Test for Eye MelanomaWithdrawnNCT00406120